Filed under Rule 424(b)(3) and (7) of the Securities Act of 1933,
relating to Registration No. 333-132865

Supplement No. 11 to Prospectus Supplement Dated March 31, 2006
and Prospectus Dated March 30, 2006

Intel Corporation

$1,600,000,000
2.95% Junior Subordinated Convertible Debentures due 2035

And

Shares of Common Stock Issuable Upon Conversion of the Debentures

     This supplement no. 11 to the prospectus supplement dated March 31, 2006 and the prospectus dated March 30, 2006 relates to the resale by selling securityholders of Intel Corporation’s 2.95% Junior Subordinated Convertible Debentures Due 2035 and the shares of Intel common stock issuable upon conversion of the debentures.

     You should read this supplement no. 11 in conjunction with the prospectus supplement dated March 31, 2006, the prospectus dated March 30, 2006, and all supplements to the prospectus supplement, which should be delivered in conjunction with this supplement no. 11. This supplement no. 11 is not complete without, and may not be delivered or used except in conjunction with, the prospectus and prospectus supplement, including supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4, supplement no. 5, supplement no. 6, supplement no. 7, supplement no. 8, supplement no. 9, supplement no. 10 and any other amendments or supplements to them. This supplement no. 11 is qualified by reference to the prospectus supplement and the prospectus, except to the extent that the information provided by this supplement no. 11 supersedes information contained in the prospectus supplement, supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4, supplement no. 5, supplement no. 6, supplement no. 7, supplement no. 8, supplement no. 9 and supplement no. 10.

     Investing in the debentures and the common stock issuable upon conversion of the debentures involves risk. See the discussion entitled “Risk Factors” beginning on page S-5 of the prospectus supplement dated March 31, 2006.

     Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this supplement no. 11, the prospectus supplement dated March 31, 2006 or the prospectus dated March 30, 2006. Any representation to the contrary is a criminal offense.

     The table under the caption “Selling Securityholders” beginning on page S-54 of the prospectus supplement, as supplemented by supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4, supplement no. 5, supplement no. 6, supplement no. 7, supplement no. 8, supplement no. 9 and supplement no. 10 is hereby supplemented and amended by updating information as to certain selling securityholders identified in the table below and adding to it certain selling securityholders identified in the table below. We prepared this table based on information supplied to us by the selling securityholders named in the table below on or prior to October 27, 2006. Information about the selling securityholders may change over time. If required, any changed or new information given to us will be set forth in supplements to the prospectus supplement or amendments to the registration statement of which the prospectus, prospectus supplement and the supplements thereto, are a part, if and when necessary.

     We have assumed for purposes of the table below that the selling securityholders will sell all of the debentures and all of the common stock issuable upon conversion of the debentures pursuant to this supplement no. 11, the prospectus supplement and the prospectus, and that any other shares of our common stock beneficially owned by the selling securityholders will continue to be beneficially owned.

     Except as set forth below, none of the selling securityholders has, or within the past three years has had, any position, office or other material relationship with us or any of our predecessors or affiliates.

     The selling securityholders identified below may have sold, transferred or otherwise disposed of, pursuant to transactions exempt from the registration requirements of the Securities Act of 1933, as amended, all or a portion of their debentures since the date on which they provided the information regarding their debentures.

		Principal Amount
		of Debentures								Number of Shares of
		Beneficially				Percentage of				Common Stock				Number of Shares of				Natural Person(s) with
		Owned and				Debentures				Issuable that May Be				Common Stock Beneficially				Voting or Investment
Name of Selling Securityholder (1)		Offered (USD) (2)				Outstanding (%)				Sold(3)(4)				Owned after the Offering(5)				Power
American Century Capital Portfolios, Inc.- Equity Income Fund			34,166,000				2.14%				1,083,616				0			Phil Davidson, Scott Moore and Kevin Toney
Credit Suisse Securities LLC (#) (6)			7,425,000				(7)				235,493				0				(8)
GLG Global Convertible Fund PLC			10,000,000				*				317,162				0			Emmanuel Roman, Noam Gottesman, Pierre Lagrange
GLG Investments PLC-sub-fund: GLG Global Convertible UCITS Fund			16,000,000				1.00%				507,459				0			Emmanuel Roman, Noam Gottesman, Pierre Lagrange
GLG Market Neutral Fund			1,000,000				*				31,716				0			Emmanuel Roman, Noam Gottesman, Pierre Lagrange
JP Morgan Securities Inc. (#)(9)			1,000,000				(10)				31,716				0				(11)
Ramius Master Fund Ltd.			51,000				*				1,618				0				(12)
UBS Securities LLC (#)(13)			26,000,000				(14)				824,621				2,233,690				(15)

The date of the supplement no. 11 is October 27, 2006.